# Tirzepatide SURMOUNT-2: weight loss in type 2 diabetes

Source: https://pepvault.app/research/tirzepatide-surmount-2-2023

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Tirzepatide](https://pepvault.app/research#tirzepatide)

Randomized trial · people

# Tirzepatide 15 mg: 14.7% weight loss at 72 weeks in SURMOUNT-2

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In people with obesity and type 2 diabetes, both tirzepatide doses tested led to far more weight loss than placebo over 72 weeks, with mainly gut-related side effects.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 938
- **Published:** 2023
- **Journal:** Lancet

## What they tested

Does weekly tirzepatide help adults with obesity and type 2 diabetes lose weight compared with placebo, and how safe is it?

## How the study was done

A double-blind, randomized, placebo-controlled phase 3 trial in 938 adults across seven countries with a BMI of 27 kg/m2 or higher and HbA1c (a 3-month average of blood sugar) of 7-10%. They got weekly tirzepatide shots under the skin at 10 mg or 15 mg, or placebo (a dummy shot), for 72 weeks.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 72, average bodyweight change was -12.8% in the 10 mg arm, -14.7% in the 15 mg arm and -3.2% on placebo. That put the 10 mg arm -9.6 percentage points and the 15 mg arm -11.6 percentage points ahead of placebo. Between 79% and 83% of people on tirzepatide lost at least 5% of their weight, against 32% on placebo. Side effects were mostly gut-related, such as nausea, diarrhea and vomiting, and mostly mild to moderate; fewer than 5% stopped treatment because of them, 68 people (7%) overall had a serious adverse event, and the 2 deaths in the 10 mg arm were judged by the investigator to be unrelated to the drug.

## What it doesn’t show

Everyone in the trial had type 2 diabetes with HbA1c of 7-10%, so the results apply to that group, and it ran for 72 weeks. The trial was funded by Eli Lilly and Company.

## The paper

Garvey et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023.

- [PubMed (PMID 37385275)](https://pubmed.ncbi.nlm.nih.gov/37385275/)
- [The paper (DOI 10.1016/S0140-6736(23)01200-X)](https://doi.org/10.1016/S0140-6736%2823%2901200-X)
- [ClinicalTrials.gov (NCT04657003)](https://clinicaltrials.gov/study/NCT04657003)

## The compound

- [Tirzepatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

## With this study

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [All 15 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Tirzepatide

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026) Randomized trial · people · 2026
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025) Randomized trial · people · 2025
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238) Randomized trial · people · 2025
- [Tirzepatide: about 75% of weight lost was fat in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39996356) Randomized trial · people · 2025
- [Tirzepatide: most reached a weight plateau by week 72 in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-and-surmount-4-2025) Randomized trial · people · 2025
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025) Randomized trial · people · 2025
- [Every study on Tirzepatide](https://pepvault.app/research#tirzepatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [All 15 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Tirzepatide](https://pepvault.app/research#tirzepatide)

## The library

- [Tirzepatide](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
